Application of Time Restriction Feeding in Patients With Type 2 Diabetes Mellitus

Running, not enrolling · Not applicable

Conditions studied: Type 2 Diabetes

In brief

In this 3-week interventional study, the investigators hypothesize that therapeutic Time-Restricted Feeding in patients with poorly controlled Type 2 diabetes mellitus (T2DM) can improve their mean glucose or estimated glycated hemoglobin levels with the same dose, or even reduced dose, of antidiabetics.

Key facts

Study ID

NCT05015504

Run by

OhioHealth

People needed

30

Starts

2022-02-10

Expected to finish

2026-12-01

Last updated by the study team

2026-08-03

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years and < 65 years
• With the diagnosis of type 2 diabetes
• A1c >= 8.0 on the most recent test in the 3 months before enrollment
• Have been on stable antidiabetics in the 3 months before enrollment
• OhioHealth Patient

You may not qualify if…

• Pregnant or breastfeeding patients
• Severe hypoglycemic episodes (defined as having low blood glucose levels that requires assistance from another person to treat) in the past 12 months
• Unable to give informed consent
• Currently enrolled in another therapeutic study
• Thyroid dysfunction, as defined by abnormal thyroid function test results within the past 6 months
• Advanced stage of renal (stage 4 or above) or hepatic (cirrhosis) or respiratory (needs oxygen) or heart failure (NYHA class 3 or above)
• Active infection or malignancy
• Dementia, or other significant mental impairment that would, in the opinion of the investigator, impede patient self-reporting
• Clinician-reported history of patient non-adherence

Where it is running

• OhioHealth Castrop Health Center — Athens, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.